World's Best Scientists 2026 revealed!
Rüdiger Hehlmann

Rüdiger Hehlmann

D-Index & Metrics

Medicine

D-Index
78
Citations
28231
World Ranking
17877
National Ranking
939

Overview

Rüdiger Hehlmann is affiliated with Heidelberg University in Germany and has contributed extensively to the field of medicine, particularly focusing on hematology and leukemia research. Their scholarly output includes numerous publications related to chronic myeloid leukemia (CML) and related hematologic disorders.

Their main fields of study encompass medicine with specialization in subfields such as hematology, genetics, rheumatology, organic chemistry, and public health, environmental, and occupational health.

Key topics of research covered by their work include:

  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Eosinophilic Disorders and Syndromes
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Fungal Plant Pathogen Control

Their recent research papers include:

  • The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia (2020) published in Leukemia
  • European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia (2023) published in Leukemia
  • High-risk additional chromosomal abnormalities at low blast counts herald death by CML (2020) published in Leukemia
  • Chronic Myeloid Leukemia in 2020 (2020) published in HemaSphere
  • The New ELN Recommendations for Treating CML (2020) published in Journal of Clinical Medicine

Frequent coauthors collaborating with Rüdiger Hehlmann include:

  • Andreas Hochhaus
  • Susanne Saußele
  • Dietger Niederwieser
  • Markus Pfirrmann
  • Alice Fabarius

The primary venues for their publications are:

  • Leukemia
  • Blood
  • Cellular Therapy and Transplantation
  • HemaSphere
  • Leukemia & lymphoma/Leukemia and lymphoma

Best Publications

  • European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

    Michele Baccarani;Michael W. Deininger;Gianantonio Rosti;Andreas Hochhaus

  • Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

    Michele Baccarani;Giuseppe Saglio;John Goldman;Andreas Hochhaus

  • Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

    Michele Baccarani;Jorge Cortes;Fabrizio Pane;Dietger Niederwieser

  • Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

    Amy V. Jones;Sebastian Kreil;Katerina Zoi;Katherine Waghorn

  • Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

    Timothy P Hughes;Michael W Deininger;Andreas Hochhaus;Susan Branford

  • A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.

    Joerg Hasford;Markus Pfirrmann;Rüdiger Hehlmann;Norman C. Allan

  • Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

    Tiziano Barbui;Giovanni Barosi;Gunnar Birgegard;Francisco Cervantes

  • Chronic myeloid leukaemia

    Rüdiger Hehlmann;Andreas Hochhaus;Michele Baccarani

  • Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score

    Joerg Hasford;Michele Baccarani;Verena Hoffmann;Joelle Guilhot

  • An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: Developed for the American Society of Hematology

    Richard T. Silver;Steven H. Woolf;Rüdiger Hehlmann;Frederick R. Appelbaum

  • Philadelphia chromosome-negative classical myeloproliferative neoplasms: Revised management recommendations from European LeukemiaNet

    Tiziano Barbui;Ayalew Tefferi;Alessandro M. Vannucchi;Francesco Passamonti

  • Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML).

    B. Hanfstein;M. C. Müller;R. Hehlmann;P. Erben

  • Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia

    Rüdiger Hehlmann;Michael Lauseker;Susanne Jung-Munkwitz;Armin Leitner

  • Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV

    Rüdiger Hehlmann;Martin C. Müller;Michael Lauseker;Benjamin Hanfstein

  • Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV

    Alice Fabarius;Armin Leitner;Andreas Hochhaus;Martin C. Müller

  • Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

    Rüdiger Hehlmann;Michael Lauseker;Susanne Saußele;Markus Pfirrmann

  • The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2

    Andreas Reiter;Christoph Walz;Ann Watmore;Claudia Schoch

  • How I treat CML blast crisis

    Rüdiger Hehlmann

  • Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia

    M. Pfirrmann;M. Baccarani;S. Saussele;J. Guilhot

  • Specific Detection of Aspergillus Species in Blood and Bronchoalveolar Lavage Samples of Immunocompromised Patients by Two-Step PCR

    Heyko Skladny;Dieter Buchheidt;Corinna Baust;Frank Krieg-Schneider

Frequent Co-Authors

Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Stefan W. Krause
Stefan W. Krause University of Erlangen-Nuremberg
Claudia Haferlach
Claudia Haferlach Ludwig-Maximilians-Universität München
Lothar Kanz
Lothar Kanz University of Tübingen
Michael Pfreundschuh
Michael Pfreundschuh Saarland University
Susanne Schnittger
Susanne Schnittger Ludwig-Maximilians-Universität München
Andreas Reiter
Andreas Reiter Heidelberg University
Hans-Jochem Kolb
Hans-Jochem Kolb Ludwig-Maximilians-Universität München
Michael Kneba
Michael Kneba Kiel University
Michele Baccarani
Michele Baccarani University of Bologna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens the door to a wide range of related online degrees and career options in healthcare. Aspiring professionals no longer need to attend a campus full-time, as many accredited programs are now offered fully online and at a lower cost. For those interested in healthcare leadership or hospital management, exploring the cheapest mha programs online can be a practical next step after a medical degree.

Nursing professionals who want to advance their clinical expertise can consider the cheapest dnp online programs. Pharmacists or those interested in pharmacy careers may be drawn to the 3-year online pharmd programs designed for working adults.

For those focused on the intersection of healthcare and technology, a degree in healthcare informatics is increasingly sought-after. Online healthcare informatics degree programs prepare graduates to manage patient data, improve care quality, and lead digital transformation within medical facilities.

These online pathways make it easier to achieve advanced qualifications, adapt to changing healthcare needs, and pursue rewarding careers beyond traditional medicine.

Best Scientists Citing Rüdiger Hehlmann

Trending Scientists

Recently Published Articles